{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T05:10:04Z","timestamp":1751087404584,"version":"3.41.0"},"reference-count":15,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2025]]},"DOI":"10.3960\/jslrt.24065","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T22:09:02Z","timestamp":1745964542000},"page":"107-114","source":"Crossref","is-referenced-by-count":0,"title":["Composite mantle cell lymphoma and T-cell prolymphocytic leukemia: a case report"],"prefix":"10.3960","volume":"65","author":[{"given":"Emi","family":"Kemmoku","sequence":"first","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan,"},{"name":"Center for Clinical Pathology, Fujita Health University Hospital, Nagakute, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukumi","family":"Tokumasu","sequence":"additional","affiliation":[{"name":"Department of Clinical laboratories, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nonaka","sequence":"additional","affiliation":[{"name":"Department of Clinical laboratories, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Yanada","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"},{"name":"Department of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waki","family":"Hosoda","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Campo E, Jaffe ES, Cook JR <i>et al.<\/i> The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022; 140: 1229-1253.","DOI":"10.1182\/blood.2022015851"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Alaggio R, Amador C, Anagnostopoulos I, <i>et al.<\/i> The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36: 1720-1748.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Raffeld M, Jaffe ES. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood. 1991; 78: 259-263.","DOI":"10.1182\/blood.V78.2.259.259"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Staber PB, Herling M, Bellido M <i>et al.<\/i> Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood. 2019; 134: 1132-1143.","DOI":"10.1182\/blood.2019000402"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Garand R, Goasguen J, Brizard A <i>et al.<\/i> Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Fran\u00e7ais d\u2019H\u00e9matologie Cellulaire. Br J Haematol. 1998; 103: 488-494.","DOI":"10.1046\/j.1365-2141.1998.00977.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hu Z, Medeiros LJ, Fang L <i>et al.<\/i> Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia. Am J Hematol. 2017; 92: 441-447.","DOI":"10.1002\/ajh.24679"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kim H. Composite lymphoma and related disorders. Am J Clin Pathol. 1993; 99: 445-451.","DOI":"10.1093\/ajcp\/99.4.445"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 K\u00fcppers R, D\u00fchrsen U, Hansmann ML. Pathogenesis, diagnosis, and treatment of composite lymphomas. Lancet Oncol. 2014; 15: e435-e446.","DOI":"10.1016\/S1470-2045(14)70153-6"},{"key":"9","unstructured":"9 Xiao Z, Ni Y, Yin G <i>et al.<\/i> Mantle cell lymphoma concurrent with T-large granular lymphocytic leukemia: report of a case and review of literature. Int J Clin Exp Pathol. 2015; 8: 3365-3369."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gonz\u00e1lez-Gasc\u00f3n Y, Mar\u00edn I, Menarguez J, Kwon M <i>et al.<\/i> Composite Lymphoma Containing Mantle Cell and Peripheral T-cell Lymphoma, Not Otherwise Specified: A Report of 2 Cases Treated With Up-front Autologous Stem Cell Transplantation. Appl Immunohistochem Mol Morphol. 2020; 28: e94-e98.","DOI":"10.1097\/PAI.0000000000000769"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Gorodetskiy VR, Probatova NA, Kupryshina NA <i>et al.<\/i> Simultaneous Presentation of Leukemic Non-Nodal Mantle Cell Lymphoma and Gamma-Delta T-Large Granular Lymphocytic Leukemia in a Patient with Rheumatoid Arthritis. Cancer Manag Res. 2020; 12: 9449-9457.","DOI":"10.2147\/CMAR.S261910"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Pina-Oviedo S, Motwani P. Composite ALK-negative anaplastic large-cell lymphoma and mantle cell lymphoma. Blood. 2023; 141: 556.","DOI":"10.1182\/blood.2022018324"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tao J, Wasik MA. Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings. Lab Invest. 2001; 81: 429-437.","DOI":"10.1038\/labinvest.3780251"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol. 2007; 38: 1293-1304.","DOI":"10.1016\/j.humpath.2007.05.020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ohue Y, Nishikawa H., Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target? Cancer Sci. 2019; 110: 2080-2089.","DOI":"10.1111\/cas.14069"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/2\/65_24065\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:45:34Z","timestamp":1751085934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/2\/65_24065\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24065","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24065"}}